Latest Partnerships News

Audeara Limited has secured a five-year licensing agreement with Eastech (Huizhou) Co., Ltd. to bring its advanced hearing technology to China’s booming medical device market, leveraging major e-commerce platforms for distribution.

Askari Metals has confirmed the legal validity of its Nejo Gold and Copper Project licences in Ethiopia, paving the way for a comprehensive exploration campaign in a highly prospective mineral region.

VEEM Limited has renewed a six-year, $65 million contract to supply critical components for Australia's Collins Class submarines, reinforcing its long-standing defence partnership and projecting stronger financial performance in FY26.

Hazer Group has filed patents for a breakthrough graphite purification process that could unlock access to the lucrative battery materials market amid tightening global supply. This innovation positions Hazer to meet surging demand for high-purity graphite essential for lithium-ion batteries.

Southern Cross Electrical Engineering has announced over $110 million in new and renewed contracts, reinforcing its position in Australia’s infrastructure services and manufacturing sectors.

Spark New Zealand is selling 75% of its data centre business to Pacific Equity Partners for up to $705 million, aiming to accelerate capacity expansion amid rising cloud and AI demand.

TasFoods announces plans to divest its premium artisan cheese brand Pyengana Dairy, aiming to refocus capital on its poultry supply chain. The sale, potentially to a major shareholder-backed fund, marks a strategic pivot for the company.

Livium Ltd and Mineral Resources Ltd have formalised a 50 – 50 joint venture to commercialise the innovative LieNA® lithium processing technology, aiming to license it globally despite current market headwinds.

Litchfield Minerals Limited has launched a $1.5 million capital raising to fast-track exploration at its Northern Territory copper-zinc projects, including the advanced Oonagalabi asset. Recent drilling and geophysical surveys highlight promising mineralisation and near-term growth potential.

Etherstack’s US subsidiary has locked in a significant seven-year Master Supply Agreement with AT&T, promising steady revenue and validating its mission-critical telecom technology.

Syntara Limited is set to update investors on the clinical progress of its lead drug candidate amsulostat, targeting myelofibrosis, in a webinar scheduled for 11 August 2025. The company highlights recent regulatory milestones and advancing trials.

Syntara Limited has received FDA guidance recommending a Phase 2 controlled trial for its lead drug amsulostat in myelofibrosis, setting the stage for a pivotal Phase 3 study. The company is poised to refine its clinical strategy while advancing a diverse pipeline with key data milestones ahead.